Predictors of biochemical failure in patients undergoing prostate whole‐gland salvage cryotherapy: a novel risk stratification model
Open Access
- 7 March 2013
- journal article
- research article
- Published by Wiley in BJU International
- Vol. 112 (4) , E256-E261
Abstract
What's known on the subject? and What does the study add?: Previous studies have identified the most important prognostic factors of the likely outcomes of salvage prostate whole‐gland ablation, including initial clinical stage, biopsy G leason score, and PSA (total and doubling time). There is potential for further optimization of candidate selection for salvage cryoablation with curative intent and nadir PSA achieved after whole‐gland cryotherapy may provide additional prognostic value. The study shows that the most important prognostic factors of biochemical progression‐free survival for patients who have undergone whole‐gland salvage prostate cryotherapy are nadir PSA achieved after therapy and pre‐therapy biopsy G leason score. Based on these two prognostic variables, we have identified risk stratification groups (low, intermediate and high) which help predict the expected outcomes of salvage whole‐gland prostate cryotherapy in a given patient. This risk stratification constitutes a useful clinical tool in defining which patients maybe best suited for this local salvage treatment method. Objective: To assess the prognostic variables predicting the risk of biochemical progression‐free survival ( bPFS ) after salvage prostate whole‐gland cryotherapy using the P hoenix definition of bPFS . Patients and Methods: A total of 132 patients underwent prostate whole‐gland salvage cryotherapy with curative intent. No patient underwent neoadjuvant/adjuvant hormonal ablative therapy, and all had extended post‐salvage prostate‐specific antigen ( PSA ) follow‐up data. Cox univariate and multivariate logistic regression analyses of potential predictors of bPFS were conducted. K aplan– M eier analyses of b PFS was also performed. Results: At a mean (range) follow‐up of 4.3 (0.9–12.7) years, the median (range) post‐cryotherapy nadir PSA achieved was 0.17 (0–33.9) ng/ mL . On multivariate analysis, predictors of bPFS were nadir PSA post‐cryotherapy and pre‐salvage biopsy G leason score ( P < 0.001 and 0.009, respectively). Risk stratification groups (low, intermediate and high) were developed based on the presence of zero, one or two adverse risk factors, the risk factors being either a nadir PSA >2.5 ng/ mL or biopsy G leason score ≥7, with the K aplan– M eier bPFS curves of these risk groups being significantly different ( P = 0.02 and <0.001, respectively). Conclusions: Post‐salvage nadir PSA and pre‐salvage biopsy G leason score are important predictors of outcome in this patient cohort. Low‐, intermediate‐ and high‐risk groups can be determined based on these variables and can define patients best suited for prostate cryotherapy.Keywords
This publication has 16 references indexed in Scilit:
- Salvage Cryoablation for Locally Recurrent Prostate Cancer Following Primary RadiotherapyEuropean Urology, 2012
- Achieving the ‘bifecta’ using salvage cryotherapy for locally recurrent prostate cancer: analysis of the Cryo On‐Line Data (COLD) Registry dataBJU International, 2011
- Prognostic value of initial prostate‐specific antigen levels after salvage cryoablation for prostate cancerBJU International, 2010
- A pretreatment nomogram predicting biochemical failure after salvage cryotherapy for locally recurrent prostate cancerBJU International, 2010
- Primary Cryoablation Nadir Prostate Specific Antigen and Biochemical FailureJournal of Urology, 2009
- Twenty‐four‐month postradiation prostate biopsies are strongly predictive of 7‐year disease‐free survivalCancer, 2009
- Salvage Prostate Cryoablation: Initial Results From the Cryo On-Line Data RegistryJournal of Urology, 2008
- Presalvage prostate‐specific antigen (PSA) and PSA doubling time as predictors of biochemical failure of salvage cryotherapy in patients with locally recurrent prostate cancer after radiotherapyCancer, 2006
- PREDICTIVE VALUE OF PROSTATE SPECIFIC ANTIGEN NADIR AFTER SALVAGE CRYOTHERAPYJournal of Urology, 1998
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958